{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:06:52Z","timestamp":1789477612275,"version":"build-2803163510"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Narcolepsy type 1 (NT1) is a central disorder of hypersomnolence characterized by the selective loss of hypocretin\/orexin-producing neurons. Its pathogenesis is closely associated with HLA genetic susceptibility, environmental triggers, and T-cell-mediated autoimmune responses. In recent years, increasing attention has been paid to the role of cytokines in the immunopathology of NT1. This review summarizes current evidence regarding cytokines in NT1, including IL-6, TNF-\u03b1, IFN-\u03b3, IL-8, MCP-1\/CCL2, CCL3, IL-4, and IL-10, and critically evaluates their roles as potential pathogenic mediators, diagnostic biomarkers, disease-stage indicators, and markers of neuropsychiatric comorbidities. Current evidence suggests that IL-6, TNF-\u03b1, and IFN-\u03b3 may reflect peripheral pro-inflammatory responses and activation of the Th1\/cytotoxic T-cell axis, whereas IL-4 and IL-10 may be associated with immunoregulatory balance and emotional symptoms. However, most available studies are limited by small sample sizes, single-center cohorts, and cross-sectional designs, and their findings are influenced by sample matrix, disease stage, age, medication exposure, obesity, and neuropsychiatric comorbidities, resulting in limited consistency and reproducibility. Therefore, no single cytokine currently qualifies as an independent diagnostic biomarker, disease-staging indicator, or therapeutic target for NT1. Future studies should integrate cytokine profiles with HLA\/TCR background, cerebrospinal fluid hypocretin-1 levels, T-cell functional assays, disease stage, sample type, and neuropsychiatric phenotypes to construct multidimensional immune-phenotyping models for NT1.<\/jats:p>","DOI":"10.3389\/fneur.2026.1904069","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:37:22Z","timestamp":1789475842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytokines in narcolepsy type 1: pathogenic relevance, biomarker potential, and future directions"],"prefix":"10.3389","volume":"17","author":[{"given":"Jingqian","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Hospital of Hebei Medical University","place":["Shijiazhuang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Handan","place":["Handan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"16100","DOI":"10.1038\/nrdp.2016.100","article-title":"Narcolepsy","volume":"3","author":"Kornum","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"101993","DOI":"10.1016\/j.smrv.2024.101993","article-title":"Recent insights into the pathophysiology of narcolepsy type 1","volume":"78","author":"Vringer","year":"2024","journal-title":"Sleep Med Rev"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa2405847","article-title":"Oveporexton, an oral orexin receptor 2-selective agonist, in narcolepsy type 1","volume":"392","author":"Dauvilliers","year":"2025","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ana.26300","article-title":"Reduced numbers of corticotropin-releasing hormone neurons in narcolepsy type 1","volume":"91","author":"Shan","year":"2022","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ana.26736","article-title":"Activated wake systems in narcolepsy type 1","volume":"94","author":"Shan","year":"2023","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrneurol.2015.99","article-title":"Interactions of the histamine and hypocretin systems in CNS disorders","volume":"11","author":"Shan","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e2220911120","DOI":"10.1073\/pnas.2220911120","article-title":"Epigenetic silencing of selected hypothalamic neuropeptides in narcolepsy with cataplexy","volume":"120","author":"Seifinejad","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1799520","DOI":"10.3389\/fpsyt.2026.1799520","article-title":"Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications for precision sleep medicine","volume":"17","author":"Arias-Carri\u00f3n","year":"2026","journal-title":"Front Psych"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.5665\/sleep.3300","article-title":"DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe","volume":"37","author":"Tafti","year":"2014","journal-title":"Sleep"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e2513989122","DOI":"10.1073\/pnas.2513989122","article-title":"HLA-DQB1*03:01 strongly affects age of onset of type 1 narcolepsy independently of DQA1 and ethnicity","volume":"122","author":"Zhang","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"zsaa099","DOI":"10.1093\/sleep\/zsaa099","article-title":"Narcolepsy type 1: what have we learned from genetics?","volume":"43","author":"Ollila","year":"2020","journal-title":"Sleep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41577-023-00902-9","article-title":"The immunopathogenesis of narcolepsy type 1","volume":"24","author":"Liblau","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1038\/s41467-023-36120-z","article-title":"Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy","volume":"14","author":"Ollila","year":"2023","journal-title":"Nat Commun"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41586-018-0540-1","article-title":"T cells in patients with narcolepsy target self-antigens of hypocretin neurons","volume":"562","author":"Latorre","year":"2018","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1038\/s41467-019-13234-x","article-title":"In vivo clonal expansion and phenotypes of hypocretin-specific CD4+ T cells in narcolepsy patients and controls","volume":"10","author":"Jiang","year":"2019","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China","volume":"70","author":"Han","year":"2011","journal-title":"Ann Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"902840","DOI":"10.3389\/fimmu.2022.902840","article-title":"Narcolepsy and H1N1 influenza immunology a decade later: what have we learned?","volume":"13","author":"Buonocore","year":"2022","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e114361","DOI":"10.1371\/journal.pone.0114361","article-title":"Antigenic differences between AS03 adjuvanted influenza a (H1N1) pandemic vaccines: implications for Pandemrix-associated narcolepsy risk","volume":"9","author":"Vaarala","year":"2014","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1038\/s41467-021-22637-8","article-title":"Enhanced influenza a H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1","volume":"12","author":"Vuorela","year":"2021","journal-title":"Nat Commun"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"578383","DOI":"10.1016\/j.jneuroim.2024.578383","article-title":"Infection, vaccination and narcolepsy type 1: evidence and potential molecular mechanisms","volume":"393","author":"Ayoub","year":"2024","journal-title":"J Neuroimmunol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"11914","DOI":"10.3390\/ijms252211914","article-title":"The role of T cells in the pathogenesis of narcolepsy type 1: a narrative review","volume":"25","author":"Xu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.sleep.2021.07.024","article-title":"Narcolepsy type 1 patients have lower levels of effector memory CD4+ T cells compared to their siblings when controlling for H1N1-(Pandemrix\u2122)-vaccination and HLA DQB1*06:02 status","volume":"85","author":"Viste","year":"2021","journal-title":"Sleep Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"zsw070","DOI":"10.1093\/sleep\/zsw070","article-title":"CD4+ T-cell reactivity to orexin\/hypocretin in patients with narcolepsy type 1","volume":"40","author":"Ramberger","year":"2017","journal-title":"Sleep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"10956","DOI":"10.1073\/pnas.1603325113","article-title":"CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice","volume":"113","author":"Bernard-Valnet","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ana.78199","article-title":"Increased numbers of CD4+ T-cells in the hypocretin\/orexin region of narcolepsy type 1","volume":"99","author":"Shan","year":"2026","journal-title":"Ann Neurol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.molmed.2026.02.005","article-title":"Narcolepsy type 1: an autoimmune disease","volume":"32","author":"Wang","year":"2026","journal-title":"Trends Mol Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0169836","DOI":"10.1371\/journal.pone.0169836","article-title":"Narcolepsy type 1 is associated with a systemic increase and activation of regulatory T cells and with a systemic activation of global T cells","volume":"12","author":"Lecendreux","year":"2017","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1249405","DOI":"10.3389\/fimmu.2023.1249405","article-title":"The transcriptomics profiling of blood CD4 and CD8 T-cells in narcolepsy type I","volume":"14","author":"Khajavi","year":"2023","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrn2576","article-title":"How (and why) the immune system makes us sleep","volume":"10","author":"Imeri","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1212\/wnl.50.4.1149","article-title":"In vivo and in vitro immune variables in patients with narcolepsy and HLA-DR2 matched controls","volume":"50","author":"Hinze-Selch","year":"1998","journal-title":"Neurology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bbi.2013.12.019","article-title":"Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study","volume":"37","author":"Dauvilliers","year":"2014","journal-title":"Brain Behav Immun"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.bbi.2015.03.004","article-title":"Cerebrospinal fluid cytokine levels in type 1 narcolepsy patients very close to onset","volume":"49","author":"Kornum","year":"2015","journal-title":"Brain Behav Immun"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.humimm.2014.06.023","article-title":"Increased plasma IL-6, IL-8, TNF-alpha, and G-CSF in Japanese narcolepsy","volume":"75","author":"Tanaka","year":"2014","journal-title":"Hum Immunol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"155103","DOI":"10.1016\/j.cyto.2020.155103","article-title":"Cytokines in narcolepsy: a systematic review and meta-analysis","volume":"131","author":"Mohammadi","year":"2020","journal-title":"Cytokine"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12883-025-04359-2","article-title":"Association between cytokines and neuropsychiatric symptoms in paediatric narcolepsy patients: a cross-sectional study","volume":"25","author":"Wei","year":"2025","journal-title":"BMC Neurol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"106877","DOI":"10.1016\/j.sleep.2025.106877","article-title":"Association between lipopolysaccharide-binding protein levels and disease severity in pediatric narcolepsy: a cross-sectional study","volume":"137","author":"Liu","year":"2026","journal-title":"Sleep Med"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/bio.2015.0059","article-title":"Impact of whole-blood processing conditions on plasma and serum concentrations of cytokines","volume":"14","author":"Lee","year":"2016","journal-title":"Biopreserv Biobank"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1034\/j.1399-0039.1999.540204.x","article-title":"Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy","volume":"54","author":"Hohjoh","year":"1999","journal-title":"Tissue Antigens"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.sleep.2013.04.030","article-title":"Increased plasma level of tumor necrosis factor \u03b1 in patients with narcolepsy in Taiwan","volume":"14","author":"Chen","year":"2013","journal-title":"Sleep Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.smim.2014.05.004","article-title":"Regulation of NF-\u03baB by TNF family cytokines","volume":"26","author":"Hayden","year":"2014","journal-title":"Semin Immunol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"6822","DOI":"10.1111\/jcmm.14566","article-title":"Molecular mechanism of tumour necrosis factor alpha regulates hypocretin (orexin) expression, sleep and behaviour","volume":"23","author":"Zhan","year":"2019","journal-title":"J Cell Mol Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1038\/cddis.2012.123","article-title":"IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease","volume":"3","author":"Barcia","year":"2012","journal-title":"Cell Death Dis"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jaut.2015.03.003","article-title":"Impact of cytokine in type 1 narcolepsy: role of pandemic H1N1 vaccination?","volume":"60","author":"Lecendreux","year":"2015","journal-title":"J Autoimmun"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/acn3.50908","article-title":"Children with narcolepsy type 1 have increased T-cell responses to orexins","volume":"6","author":"Cogswell","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/brain\/awab455","article-title":"Influenza vaccination induces autoimmunity against orexinergic neurons in a mouse model for narcolepsy","volume":"145","author":"Bernard-Valnet","year":"2022","journal-title":"Brain"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"175549","DOI":"10.1016\/j.ejphar.2023.175549","article-title":"Myricetin ameliorates experimental autoimmune myocarditis in mice by modulating immune response and inhibiting MCP-1 expression","volume":"942","author":"Nie","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"107598","DOI":"10.1016\/j.intimp.2021.107598","article-title":"MCP-1: function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1084\/jem.20160897","article-title":"High-dimensional single-cell analysis reveals the immune signature of narcolepsy","volume":"213","author":"Hartmann","year":"2016","journal-title":"J Exp Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jocn.2024.07.011","article-title":"Association between cytokines and symptoms of depression and anxiety in patients with type 1 narcolepsy","volume":"126","author":"Yuan","year":"2024","journal-title":"J Clin Neurosci"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"100591","DOI":"10.1016\/j.ijchp.2025.100591","article-title":"Narcolepsy and psychiatric comorbidity: a review of the literature","volume":"25","author":"Verstraete","year":"2025","journal-title":"Int J Clin Health Psychol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/17576180.2025.2544521","article-title":"Effect of delayed blood centrifugation on cytokine quantitation in serum and plasma","volume":"17","author":"Yang","year":"2025","journal-title":"Bioanalysis"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ymeth.2013.04.005","article-title":"Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples","volume":"61","author":"Keustermans","year":"2013","journal-title":"Methods"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.smrv.2007.07.010","article-title":"Narcolepsy: immunological aspects","volume":"12","author":"Overeem","year":"2008","journal-title":"Sleep Med Rev"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1600-0404.1990.tb00978.x","article-title":"CSF immune variables in patients with narcolepsy","volume":"81","author":"Fredrikson","year":"1990","journal-title":"Acta Neurol Scand"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jocn.2024.01.007","article-title":"Association between cytokines and fatigue in patients with type 1 narcolepsy","volume":"120","author":"Yang","year":"2024","journal-title":"J Clin Neurosci"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"102167","DOI":"10.1016\/j.smrv.2025.102167","article-title":"Central disorders of hypersomnolence: a narrative review on current and potential biomarkers","volume":"84","author":"Tai","year":"2025","journal-title":"Sleep Med Rev"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1904069\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:37:23Z","timestamp":1789475843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1904069\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":60,"alternative-id":["10.3389\/fneur.2026.1904069"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1904069","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1904069"}}